Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Conatus Pharmaceutic (CNAT)

5.10 +0.14 (+2.82%)

6/23/2017  4:00pm

Open:

4.96

Pre. Close:

4.96

High:

5.10

Low:

4.77

Volume:

3,700,855

Market Cap:

133.46M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.17 - 5.63

5.63 - 6.31

Low:

4.52 - 4.83

4.83 - 5.29

Close:

4.95 - 5.36

5.36 - 5.98

Technical analysis  (as of: 2017-06-23 4:33:17 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 6.09     One year: 6.49

Support:

Support1: 4.65    Support2: 3.87

Resistance:

Resistance1: 5.21    Resistance2: 5.56

Pivot:

5.03

Moving Averages:

MA(5): 4.98     MA(20): 5.06

MA(100): 5.57     MA(250): 3.71

MACD:

MACD(12,26): -0.26     Signal(12,26,9): -0.33

%K %D:

%K(14,3): 56.73     %D(3): 48.95

RSI:

RSI(14): 44.45

52-Week:

High: 9.40  Low: 1.45  Change(%): 139.4

Average Vol(K):

3-Month: 1078  10-Days 675

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CNAT has closed below upper band by 39.1%. Bollinger Bands are 66.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to CNAT's normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 20 Dec 2016 14:15:00 GMT
Conatus Pharmaceuticals Inc - A Deal Emerges With Novartis As The NASH Field ...

Mon, 15 May 2017 18:56:15 GMT
Revisiting Conatus Pharmaceuticals Due To Recent Pipeline Expansion Talks

Mon, 26 Jun 2017 00:00:00 GMT
Conatus Pharmaceuticals Inc. (NasdaqGM:CNAT) Shareholder Yield in Focus

Thu, 04 May 2017 12:56:15 GMT
Company Spotlight: Conatus Pharma

Thu, 04 May 2017 23:48:45 GMT
Conatus Pharmaceuticals' (CNAT) CEO Steve Mento on Q1 2017 Results - Earnings ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

29.20

Shares Float (M)

23.56

% Held by Insiders

26.83

% Held by Institutions

34.40

Shares Short (K)

923

Shares Short Prior Month (K)

794

Stock Financials

EPS

-1.090

EPS Est. Current Year

-0.830

EPS Est. Next Year

0.190

EPS Est. Next Quarter

-0.200

Forward EPS

0.190

Book Value (p.s.)

0.740

PEG Ratio

-0.16

Profit Margin

Operating Margin

-336.64

Return on Assets (ttm)

-27.5

Return on Equity (ttm)

-102.7

Qtrly Rev. Growth

Gross Profit (p.s.)

0.027

Sales Per Share

EBITDA (p.s.)

-0.895

Qtrly Earnings Growth

Operating Cash Flow (M)

25.89

Levered Free Cash Flow (M)

19.26

FoxReading.com

Valuation

P/E

-4.68

P/E Growth Ratio

0.03

P/BV

6.89

P/S

465375008.00

P/CF

5.75

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.